» Articles » PMID: 8748662

Characterisation of Extracellular Amino Acids in Striatum of Freely Moving Rats by in Vivo Microdialysis

Overview
Specialties Neurology
Physiology
Date 1995 Jan 1
PMID 8748662
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

To investigate the characteristics of extracellular amino acids released from the striatum, we performed in vivo microdialysis in non-anaesthetised, freely moving rats. Amino acids were determined after precolumn derivatisation with o-phthalaldehyde by high-performance liquid chromatography and fluorescence detection. The omission of Ca2+ in the perfusion medium partially decreased the basal concentration of aspartate and glutamate. This shows that a small fraction of basal concentration of aspartate and glutamate is of neuronal origin. The effect of high K+ and veratrine stimulation was evaluated in the presence or absence of Ca2+ or tetrodotoxin (1 microM). High K+ and veratrine caused a remarkable increase in the aspartate and glutamate efflux. The omission of Ca2+ only partially decreased K(+)-stimulated aspartate and glutamate efflux. Tetrodotoxin completely antagonised veratrine-stimulated aspartate and glutamate efflux. Although glycine and taurine releases were stimulated by high K+ and veratrine, their release was not always antagonised with Ca2+ omission or tetrodotoxin inclusion. Thus, the neuronal origin of stimulated release of glycine and taurine is unclear. Although tetrodotoxin sensitivity and Ca2(+)-dependency are regarded as a basic criterion for classical neurotransmitters in microdialysis experiments, they should not be adapted to the physiological characteristics of the release of amino acids.

Citing Articles

Collection of nanoliter microdialysate fractions in plugs for off-line in vivo chemical monitoring with up to 2 s temporal resolution.

Wang M, Slaney T, Mabrouk O, Kennedy R J Neurosci Methods. 2010; 190(1):39-48.

PMID: 20447417 PMC: 2885530. DOI: 10.1016/j.jneumeth.2010.04.023.


Glycine as a neurotransmitter in the forebrain: a short review.

Hernandes M, Troncone L J Neural Transm (Vienna). 2009; 116(12):1551-60.

PMID: 19826900 DOI: 10.1007/s00702-009-0326-6.


The effects of systemically administered taurine and N-pivaloyltaurine on striatal extracellular dopamine and taurine in freely moving rats.

Salimaki J, Scriba G, Piepponen T, Rautolahti N, Ahtee L Naunyn Schmiedebergs Arch Pharmacol. 2003; 368(2):134-41.

PMID: 12898127 DOI: 10.1007/s00210-003-0776-6.


D-Serine differently modulates NMDA receptor function in rat CA1 hippocampal pyramidal cells and interneurons.

Martina M, Krasteniakov N, Bergeron R J Physiol. 2003; 548(Pt 2):411-23.

PMID: 12611916 PMC: 2342854. DOI: 10.1113/jphysiol.2002.037127.


Taurine infused intrastriatally elevates, but intranigrally decreases striatal extracellular dopamine concentration in anaesthetised rats.

Ruotsalainen M, Heikkila M, Lillsunde P, Seppala T, Ahtee L J Neural Transm (Vienna). 1996; 103(8-9):935-46.

PMID: 9013387 DOI: 10.1007/BF01291784.


References
1.
Westerink B, Damsma G, DE VRIES J . Effect of ouabain applied by intrastriatal microdialysis on the in vivo release of dopamine, acetylcholine, and amino acids in the brain of conscious rats. J Neurochem. 1989; 52(3):705-12. DOI: 10.1111/j.1471-4159.1989.tb02512.x. View

2.
Westerink B, Hofsteede H, Damsma G, DE VRIES J . The significance of extracellular calcium for the release of dopamine, acetylcholine and amino acids in conscious rats, evaluated by brain microdialysis. Naunyn Schmiedebergs Arch Pharmacol. 1988; 337(4):373-8. DOI: 10.1007/BF00169526. View

3.
Matthews J, Altman D, Campbell M, Royston P . Analysis of serial measurements in medical research. BMJ. 1990; 300(6719):230-5. PMC: 1662068. DOI: 10.1136/bmj.300.6719.230. View

4.
Nicholls D . Release of glutamate, aspartate, and gamma-aminobutyric acid from isolated nerve terminals. J Neurochem. 1989; 52(2):331-41. DOI: 10.1111/j.1471-4159.1989.tb09126.x. View

5.
Maura G, Carbone R, Raiteri M . Aspartate-releasing nerve terminals in rat striatum possess D-2 dopamine receptors mediating inhibition of release. J Pharmacol Exp Ther. 1989; 251(3):1142-6. View